Patent Dispute Is Brewing Involving The St. Regis Mohwak Tribe

There’s a patent dispute brewing involving the St. Regis Mohawk tribe and a health product company. Karen Johnson has details.


Lawmakers in the U.S. House of Representatives and the U.S. Senate are launching assaults against the patent transfers between drugmaker Allergan and the St. Regis Mohawk Tribe, and the tribe is fighting back. The House Committee on Oversight and Government Reform has ordered the maker of Restasis to answer several questions about the deal. Allergan is facing a deadline of today for the information.
Meanwhile, in the Senate, Claire McCaskill, D-Mo., has drafted a bill stating that tribal sovereignty cannot be used to block a patent review. And four Democratic senators have submitted a letter to the Senate Judiciary Committee asking that body to investigate the tribe’s acquisition of the patents. Drugmaker Allergan announced on Sept. 8 it had transferred its patents on the eye drug to the St. Regis Mohawk Tribe to protect the drug from a patent dispute. I’m Karen Johnson.